Daan Gene Co., Ltd. (SHE:002030)

Daan Gene Statistics

Total Valuation

Daan Gene has a market cap or net worth of CNY 8.90 billion. The enterprise value is 8.40 billion.

Market Cap	8.90B
Enterprise Value	8.40B

Important Dates

The next estimated earnings date is Saturday, August 30, 2025.

Earnings Date	Aug 30, 2025
Ex-Dividend Date	Jun 14, 2024

Share Statistics

Daan Gene has 1.40 billion shares outstanding. The number of shares has decreased by -7.43% in one year.

Current Share Class	1.40B
Shares Outstanding	1.40B
Shares Change (YoY)	-7.43%
Shares Change (QoQ)	-5.27%
Owned by Insiders (%)	1.82%
Owned by Institutions (%)	9.04%
Float	934.05M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	10.80
PB Ratio	1.09
P/TBV Ratio	1.20
P/FCF Ratio	40.78
P/OCF Ratio	25.18
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-16.50
EV / Sales	10.20
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	38.50

Financial Position

The company has a current ratio of 2.91, with a Debt / Equity ratio of 0.02.

Current Ratio	2.91
Quick Ratio	1.85
Debt / Equity	0.02
Debt / EBITDA	n/a
Debt / FCF	0.60
Interest Coverage	-84.18

Financial Efficiency

Return on equity (ROE) is -6.20% and return on invested capital (ROIC) is -5.30%.

Return on Equity (ROE)	-6.20%
Return on Assets (ROA)	-4.67%
Return on Invested Capital (ROIC)	-5.30%
Return on Capital Employed (ROCE)	-8.87%
Revenue Per Employee	476,216
Profits Per Employee	-294,194
Employee Count	1,730
Asset Turnover	0.08
Inventory Turnover	2.90

Taxes

Income Tax	-16.56M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +28.60% in the last 52 weeks. The beta is 0.66, so Daan Gene's price volatility has been lower than the market average.

Beta (5Y)	0.66
52-Week Price Change	+28.60%
50-Day Moving Average	6.08
200-Day Moving Average	6.04
Relative Strength Index (RSI)	58.68
Average Volume (20 Days)	18,458,423

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Daan Gene had revenue of CNY 823.85 million and -508.95 million in losses. Loss per share was -0.37.

Revenue	823.85M
Gross Profit	165.21M
Operating Income	-741.46M
Pretax Income	-543.27M
Net Income	-508.95M
EBITDA	-404.07M
EBIT	-741.46M
Loss Per Share	-0.37

Balance Sheet

The company has 890.81 million in cash and 131.14 million in debt, giving a net cash position of 759.67 million or 0.54 per share.

Cash & Cash Equivalents	890.81M
Total Debt	131.14M
Net Cash	759.67M
Net Cash Per Share	0.54
Equity (Book Value)	8.19B
Book Value Per Share	5.65
Working Capital	2.17B

Cash Flow

In the last 12 months, operating cash flow was 353.44 million and capital expenditures -135.25 million, giving a free cash flow of 218.19 million.

Operating Cash Flow	353.44M
Capital Expenditures	-135.25M
Free Cash Flow	218.19M
FCF Per Share	0.16

Margins

Gross margin is 20.05%, with operating and profit margins of -90.00% and -61.78%.

Gross Margin	20.05%
Operating Margin	-90.00%
Pretax Margin	-65.94%
Profit Margin	-61.78%
EBITDA Margin	-49.05%
EBIT Margin	-90.00%
FCF Margin	26.48%

Dividends & Yields

This stock pays an annual dividend of 0.02, which amounts to a dividend yield of 0.24%.

Dividend Per Share	0.02
Dividend Yield	0.24%
Dividend Growth (YoY)	-99.14%
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	7.43%
Shareholder Yield	7.67%
Earnings Yield	-5.72%
FCF Yield	2.45%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on May 19, 2021. It was a forward split with a ratio of 1.6.

Last Split Date	May 19, 2021
Split Type	Forward
Split Ratio	1.6

Scores

Daan Gene has an Altman Z-Score of 4.92 and a Piotroski F-Score of 2.

Altman Z-Score	4.92
Piotroski F-Score	2